259 related articles for article (PubMed ID: 29216597)
41. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
[TBL] [Abstract][Full Text] [Related]
42. Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration.
Stein MN; Malhotra J; Tarapore RS; Malhotra U; Silk AW; Chan N; Rodriguez L; Aisner J; Aiken RD; Mayer T; Haffty BG; Newman JH; Aspromonte SM; Bommareddy PK; Estupinian R; Chesson CB; Sadimin ET; Li S; Medina DJ; Saunders T; Frankel M; Kareddula A; Damare S; Wesolowsky E; Gabel C; El-Deiry WS; Prabhu VV; Allen JE; Stogniew M; Oster W; Bertino JR; Libutti SK; Mehnert JM; Zloza A
J Immunother Cancer; 2019 May; 7(1):136. PubMed ID: 31118108
[TBL] [Abstract][Full Text] [Related]
43. From dopaminergic genes to psychiatric disorders.
Hoenicka J; Aragüés M; Ponce G; Rodríguez-Jiménez R; Jiménez-Arriero MA; Palomo T
Neurotox Res; 2007 Jan; 11(1):61-72. PubMed ID: 17449449
[TBL] [Abstract][Full Text] [Related]
44. Role of the D3 dopamine receptor in nicotine sensitization.
Smith LN; Bachus SE; McDonald CG; Smith RF
Behav Brain Res; 2015 Aug; 289():92-104. PubMed ID: 25907750
[TBL] [Abstract][Full Text] [Related]
45. Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.
Allen JE; Krigsfeld G; Mayes PA; Patel L; Dicker DT; Patel AS; Dolloff NG; Messaris E; Scata KA; Wang W; Zhou JY; Wu GS; El-Deiry WS
Sci Transl Med; 2013 Feb; 5(171):171ra17. PubMed ID: 23390247
[TBL] [Abstract][Full Text] [Related]
46. The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis.
Cui Y; Prabhu V; Nguyen TB; Yadav BK; Chung YC
Int J Mol Sci; 2015 Nov; 16(11):26677-86. PubMed ID: 26561806
[TBL] [Abstract][Full Text] [Related]
47. The Expression of Dopamine Receptors Gene and their Potential Role in Targeting Breast Cancer Cells with Selective Agonist and Antagonist Drugs. Could it be the Novel Insight to Therapy?
Bakhtou H; Olfatbakhsh A; Deezagi A; Ahangari G
Curr Drug Discov Technol; 2019; 16(2):184-197. PubMed ID: 29380701
[TBL] [Abstract][Full Text] [Related]
48. Molecular characterization and differential expression of multiple goose dopamine D2 receptors.
Wang C; Liu Y; Wang H; Wu H; Gong S; Chen W; He D
Gene; 2014 Feb; 535(2):177-83. PubMed ID: 24309374
[TBL] [Abstract][Full Text] [Related]
49. Smoking Genes: A Case-Control Study of Dopamine Transporter Gene (
Ruzilawati AB; Islam MA; Muhamed SKS; Ahmad I
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287325
[TBL] [Abstract][Full Text] [Related]
50. The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent.
Zhang Q; Wang H; Ran L; Zhang Z; Jiang R
Biochem Biophys Res Commun; 2016 Aug; 476(4):260-266. PubMed ID: 27233611
[TBL] [Abstract][Full Text] [Related]
51. ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non-Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms.
Ralff MD; Kline CLB; Küçükkase OC; Wagner J; Lim B; Dicker DT; Prabhu VV; Oster W; El-Deiry WS
Mol Cancer Ther; 2017 Jul; 16(7):1290-1298. PubMed ID: 28424227
[TBL] [Abstract][Full Text] [Related]
52. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.
Ishizawa J; Kojima K; Chachad D; Ruvolo P; Ruvolo V; Jacamo RO; Borthakur G; Mu H; Zeng Z; Tabe Y; Allen JE; Wang Z; Ma W; Lee HC; Orlowski R; Sarbassov dos D; Lorenzi PL; Huang X; Neelapu SS; McDonnell T; Miranda RN; Wang M; Kantarjian H; Konopleva M; Davis RE; Andreeff M
Sci Signal; 2016 Feb; 9(415):ra17. PubMed ID: 26884599
[TBL] [Abstract][Full Text] [Related]
53. Low resilience to stress is associated with candidate gene expression alterations in the dopaminergic signalling pathway.
Azadmarzabadi E; Haghighatfard A; Mohammadi A
Psychogeriatrics; 2018 May; 18(3):190-201. PubMed ID: 29423959
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells.
Bonner ER; Waszak SM; Grotzer MA; Mueller S; Nazarian J
Neuro Oncol; 2021 Apr; 23(4):542-556. PubMed ID: 33336683
[TBL] [Abstract][Full Text] [Related]
55. [Role of dopamine receptor subtypes DRD2 and DRD5 in drug therapy of pituitary tumors].
Liu YT; Zhang Y; Wang Y; Wu ZB
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1703-1706. PubMed ID: 31216815
[No Abstract] [Full Text] [Related]
56. Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5.
Jeon HM; Oh YT; Shin YJ; Chang N; Kim D; Woo D; Yeup Y; Joo KM; Jo H; Yang H; Lee JK; Kang W; Sa J; Lee WJ; Hale J; Lathia JD; Purow B; Park MJ; Park JB; Nam DH; Lee J
Neoplasia; 2023 May; 39():100894. PubMed ID: 36972629
[TBL] [Abstract][Full Text] [Related]
57. Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.
Wagner J; Kline CL; Zhou L; Campbell KS; MacFarlane AW; Olszanski AJ; Cai KQ; Hensley HH; Ross EA; Ralff MD; Zloza A; Chesson CB; Newman JH; Kaufman H; Bertino J; Stein M; El-Deiry WS
J Clin Invest; 2018 Jun; 128(6):2325-2338. PubMed ID: 29533922
[TBL] [Abstract][Full Text] [Related]
58. Evidence for Protein-Protein Interaction between Dopamine Receptors and the G Protein-Coupled Receptor 143.
Bueschbell B; Manga P; Penner E; Schiedel AC
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361094
[TBL] [Abstract][Full Text] [Related]
59. Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [
Chukwueke CC; Nona CN; McPhee MD; Mansouri E; Rubin-Kahana DS; Martinez D; Boileau I; Hendershot CS; Le Foll B
Neuropsychopharmacology; 2021 Nov; 46(12):2112-2120. PubMed ID: 34349232
[TBL] [Abstract][Full Text] [Related]
60. ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of
Bagheri-Yarmand R; Dadu R; Ye L; Shiny Jebaraj Y; Martinez JA; Ma J; Tarapore RS; Allen JE; Sherman SI; Williams MD; Gagel RF
Mol Cancer Ther; 2021 Apr; 20(4):665-675. PubMed ID: 33536187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
